| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.24 | 3e-13 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.25 | 1e-11 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.21 | 3e-09 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.23 | 4e-09 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.17 | 7e-09 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-08 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-08 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-07 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-07 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-07 |